Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cacao | 2 | 2024 | 98 | 1.670 |
Why?
|
Cholecalciferol | 5 | 2024 | 553 | 1.200 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2023 | 1390 | 0.990 |
Why?
|
Psychiatry | 7 | 2023 | 1693 | 0.880 |
Why?
|
Vitamins | 4 | 2024 | 1635 | 0.840 |
Why?
|
Depression | 8 | 2023 | 8126 | 0.790 |
Why?
|
Mental Disorders | 9 | 2024 | 6845 | 0.740 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2020 | 0.730 |
Why?
|
Aging | 5 | 2023 | 8710 | 0.670 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 709 | 0.660 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 865 | 0.600 |
Why?
|
Telomere | 2 | 2021 | 943 | 0.580 |
Why?
|
DNA Methylation | 2 | 2023 | 4399 | 0.550 |
Why?
|
Psychotic Disorders | 2 | 2023 | 3223 | 0.520 |
Why?
|
Depressive Disorder, Major | 2 | 2023 | 4762 | 0.500 |
Why?
|
Life Style | 3 | 2024 | 3917 | 0.500 |
Why?
|
Primary Prevention | 1 | 2020 | 1186 | 0.400 |
Why?
|
Dietary Supplements | 6 | 2024 | 3415 | 0.380 |
Why?
|
Hospitals, General | 7 | 2023 | 798 | 0.380 |
Why?
|
Clozapine | 2 | 2024 | 504 | 0.330 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3801 | 0.330 |
Why?
|
Double-Blind Method | 5 | 2024 | 12341 | 0.280 |
Why?
|
Aged | 22 | 2024 | 169310 | 0.280 |
Why?
|
Thyroid Nodule | 3 | 2018 | 764 | 0.270 |
Why?
|
Cognition | 4 | 2024 | 6992 | 0.260 |
Why?
|
Hypothyroidism | 3 | 2018 | 668 | 0.240 |
Why?
|
Dyskinesias | 1 | 2024 | 79 | 0.220 |
Why?
|
Affect | 2 | 2021 | 1486 | 0.220 |
Why?
|
Referral and Consultation | 7 | 2023 | 3600 | 0.210 |
Why?
|
Minerals | 1 | 2024 | 283 | 0.200 |
Why?
|
Child Abuse, Sexual | 1 | 2024 | 403 | 0.190 |
Why?
|
Antipsychotic Agents | 3 | 2024 | 3067 | 0.190 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2024 | 294 | 0.180 |
Why?
|
Humans | 35 | 2024 | 761596 | 0.180 |
Why?
|
Dystonia | 1 | 2024 | 370 | 0.180 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26129 | 0.180 |
Why?
|
Movement Disorders | 1 | 2024 | 459 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10212 | 0.170 |
Why?
|
Vitamin D | 3 | 2023 | 3303 | 0.160 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 602 | 0.160 |
Why?
|
Comorbidity | 3 | 2023 | 10508 | 0.160 |
Why?
|
Depressive Disorder | 2 | 2021 | 3728 | 0.150 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1443 | 0.150 |
Why?
|
Alzheimer Disease | 1 | 2019 | 8601 | 0.150 |
Why?
|
Pilot Projects | 2 | 2023 | 8633 | 0.150 |
Why?
|
Genetic Markers | 1 | 2023 | 2601 | 0.130 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 517 | 0.130 |
Why?
|
Child Abuse | 1 | 2024 | 1077 | 0.130 |
Why?
|
Pharmacogenetics | 1 | 2019 | 675 | 0.120 |
Why?
|
Executive Function | 1 | 2023 | 1392 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2023 | 12973 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 592 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2421 | 0.110 |
Why?
|
Male | 15 | 2024 | 360846 | 0.110 |
Why?
|
Epithelium | 1 | 2018 | 1603 | 0.110 |
Why?
|
Female | 15 | 2024 | 392705 | 0.110 |
Why?
|
Thyroidectomy | 1 | 2018 | 908 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5672 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 220921 | 0.090 |
Why?
|
Thyroid Gland | 1 | 2018 | 1170 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7054 | 0.090 |
Why?
|
Smoking Cessation | 1 | 2022 | 2057 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1937 | 0.090 |
Why?
|
Health Surveys | 1 | 2020 | 4061 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4573 | 0.080 |
Why?
|
Genotype | 1 | 2024 | 12990 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1853 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4028 | 0.070 |
Why?
|
Risk Factors | 3 | 2024 | 74213 | 0.070 |
Why?
|
Carcinoma | 1 | 2018 | 2330 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3358 | 0.060 |
Why?
|
Schizophrenia | 2 | 2024 | 6937 | 0.060 |
Why?
|
Cohort Studies | 3 | 2024 | 41495 | 0.060 |
Why?
|
Asthma | 1 | 2024 | 6234 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5092 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2332 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22176 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5890 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1118 | 0.050 |
Why?
|
Paranoid Disorders | 1 | 2022 | 61 | 0.050 |
Why?
|
Prospective Studies | 2 | 2024 | 54423 | 0.050 |
Why?
|
Restraint, Physical | 1 | 2023 | 187 | 0.050 |
Why?
|
Adult | 3 | 2024 | 221210 | 0.040 |
Why?
|
Neoplasms | 2 | 2018 | 22173 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 386 | 0.040 |
Why?
|
Polypharmacy | 1 | 2020 | 306 | 0.040 |
Why?
|
Fish Oils | 1 | 2021 | 483 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 288 | 0.040 |
Why?
|
Child | 1 | 2024 | 80158 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2643 | 0.030 |
Why?
|
Primary Health Care | 2 | 2022 | 4687 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11122 | 0.030 |
Why?
|
Ultrasonography | 2 | 2018 | 5971 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2018 | 447 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12723 | 0.030 |
Why?
|
United States | 1 | 2021 | 72340 | 0.030 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7879 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58984 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2009 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2018 | 80647 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8466 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15733 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4244 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11076 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21355 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6484 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16592 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29629 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23996 | 0.010 |
Why?
|
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_